Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
18.12
-0.24 (-1.31%)
Feb 20, 2026, 4:00 PM EST - Market closed
Legend Biotech Analyst Ratings
Total Analysts
14
Consensus Rating
Buy
Price Target
$63.46
Upside
+250.22%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $90 → $80 | Buy | Maintains | $90 → $80 | +341.50% | Feb 4, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $60 → $50 | Strong Buy | Maintains | $60 → $50 | +175.94% | Jan 22, 2026 |
| TD Cowen | TD Cowen | Strong Buy → Hold Downgrades $62 → $21 | Strong Buy → Hold | Downgrades | $62 → $21 | +15.89% | Jan 22, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $66 | Buy | Maintains | $66 | +264.24% | Jan 20, 2026 |
| Oppenheimer | Oppenheimer | Buy Initiates $75 | Buy | Initiates | $75 | +313.91% | Jan 7, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $75 → $74 | Buy | Maintains | $75 → $74 | +308.39% | Dec 17, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $83 → $50 | Buy | Maintains | $83 → $50 | +175.94% | Dec 12, 2025 |
| UBS | UBS | Strong Buy Maintains $54 → $48 | Strong Buy | Maintains | $54 → $48 | +164.90% | Dec 8, 2025 |
| Barclays | Barclays | Buy Maintains $94 → $90 | Buy | Maintains | $94 → $90 | +396.69% | Nov 13, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $75 → $74 | Buy | Maintains | $75 → $74 | +308.39% | Nov 13, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $66 → $75 | Buy | Maintains | $66 → $75 | +313.91% | Nov 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $75 → $60 | Strong Buy | Maintains | $75 → $60 | +231.13% | Oct 17, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $78 → $76 | Buy | Maintains | $78 → $76 | +319.43% | Oct 9, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $55 → $66 | Buy | Initiates | $55 → $66 | +264.24% | Aug 27, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $77 → $78 | Buy | Maintains | $77 → $78 | +330.46% | Aug 25, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $75 → $77 | Buy | Maintains | $75 → $77 | +324.94% | Aug 12, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.